Related Experiment Video
Updated: Jul 8, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
[Basic and clinical aspects of calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with
Motoko Tanaka1, Masafumi Fukagawa
1Akebono Clinic, Department of Nephrology, Japan.
Abstract:
Special attention has been paid to the new class of therapeutic agents namely calcimimetics for hemodialysis patients with secondary hyperparathyroidism (SHPT) . Several studies have demonstrated that calcimimetics not only reduce the concentrations of PTH, Ca, P and Ca x P but also improve bone metabolic marker and quality of life in hemodialysis patients. Recently, calcimimetics has been expected as a new strategy for SHPT in Japan. In this article, we reviewed the usefulness of calcimimetics for SHPT of dialysis patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Skeleton and Calcium Homeostasis
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
